Jonathan Jay Mazelsky - 21 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President and CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
21 Feb 2024
Net transactions value
+$99,952
Form type
4
Filing time
22 Feb 2024, 17:02:03 UTC
Previous filing
16 Feb 2024
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99,952 +483 +0.59% $206.94* 82,047 21 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -483 -100% 0 21 Feb 2024 Common Stock 483 $206.94 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of Issuer common stock that vested on February 14, 2024.
F2 Not applicable.